NCT03389100View on ClinicalTrials.gov

Tau PET Imaging in the Northern Manhattan Study of Metabolism and Mind.

PHASE2Enrolling by invitationINTERVENTIONAL
Enrollment

600

Participants

Timeline

Start Date

July 24, 2018

Primary Completion Date

June 30, 2026

Study Completion Date

June 30, 2026

Conditions
Diabetes Mellitus, Type 2Pre-diabetes
Interventions
DRUG

18F-MK6240 injection

Intravenous injection of 18F-MK-6240, up to 5 mCi (185 MBq), total of one injection per PET scan (2 injections in total with an interval of 18 to 30 months)

Trial Locations (1)

10032

Columbia University Irving Medical Center, New York

All Listed Sponsors
collaborator

Hebrew Home at Riverdale

OTHER

collaborator

National Institute on Aging (NIA)

NIH

lead

Columbia University

OTHER